McKinsey, Opiods, and The Dark Side of High Performance
Earlier this week, the New York Times broke a story detailing how the prestigious consulting firm McKinsey and Company “proposed paying pharmacy companies rebates for Oxycontin [a popular opioid] overdoses.” Worse, partners at McKinsey allegedly tried to cover the evidence of their recommendation. In this episode of The Growth Equation podcast, Brad, a former McKinsey consultant himself,… The post McKinsey, Opiods, and The Dark Side of High Performance appeared first on The Growth Equation.
